Literature DB >> 23641013

The impact of mechanical circulatory support on outcomes in paediatric heart transplantation.

Phil Botha1, Ruth Solana, Jane Cassidy, Gareth Parry, Richard Kirk, Asif Hasan, Massimo Griselli.   

Abstract

OBJECTIVES: Internationally, the number of donors for cardiac transplantation has remained static, while the number of patients requiring transplantation for congenital heart disease (CHD) has increased. Although the availability of mechanical circulatory support (MCS) may increase the number of transplants performed by reducing deaths while waiting, it may also lead to increased morbidity post-transplantation. We sought to assess the impact of mechanical support on post-transplant outcomes in a single centre.
METHODS: We assessed the outcomes of paediatric (age ≤16 years) heart transplantation in a single unit in the era of mechanical support (1998-2012) by retrospective cohort study. Outcomes before (1998-2005) and after (2005-2012) the routine use of the Berlin Heart EXCOR device were contrasted.
RESULTS: A total of 167 patients underwent heart transplantation during this period. The diagnosis was dilated cardiomyopathy in 61.7%, two-ventricle CHD in 11.4%, single ventricle CHD in 16.8% and miscellaneous in 10.1%. Sixty-nine (41%) were bridged to transplant by mechanical support; with extracorporeal membrane oxygenation in 19 (28%), ventricular assist device in 40 (58%) and a combination in 10 (14.0%). Post-transplant mortality at 30 days was significantly greater in those supported by MCS than without (7 vs 1%, P < 0.05), and a greater proportion of patients had neurological (23 vs 8%, P < 0.01) and major respiratory sequelae (20 vs 4%, P < 0.001). There was no significant increase in the need for post-transplant mechanical support (10 vs 6%, P = 0.3) in those supported prior to transplant. The number of transplants performed increased from 67 in 1998-2005 to 100 in the most recent era (2005-2012), and an increased proportion of these patients have been supported mechanically prior to transplantation (51 vs 27%, P < 0.01).
CONCLUSION: Along with strategies to increase donor utilization, MCS has allowed an increase in cardiac transplant activity at the expense of a higher early mortality and morbidity.

Entities:  

Keywords:  Congestive heart failure; Mechanical circulatory assistance; Transplantation—heart

Mesh:

Year:  2013        PMID: 23641013     DOI: 10.1093/ejcts/ezt225

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Modern Outcomes of Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation.

Authors:  Brody Wehman; Kristen A Stafford; Gregory J Bittle; Zachary N Kon; Charles F Evans; Keshava Rajagopal; Nicholas Pietris; Sunjay Kaushal; Bartley P Griffith
Journal:  Ann Thorac Surg       Date:  2016-02-22       Impact factor: 4.330

2.  Preclinical animal study of the NIPRO-ventricular assist device for use in pediatric patients.

Authors:  Noritsugu Naito; Yoshiaki Takewa; Satoru Kishimoto; Kei Iizuka; Toshihide Mizuno; Tomonori Tsukiya; Minoru Ono; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2017-11-24       Impact factor: 1.731

3.  Mechanical circulatory support in pediatrics.

Authors:  Fabrizio Gandolfo; Fabrizio De Rita; Asif Hasan; Massimo Griselli
Journal:  Ann Cardiothorac Surg       Date:  2014-09

4.  Early primary graft failure after a pediatric heart transplant and successful rescue with plasmapheresis, immunoglobulins, and alemtuzumab.

Authors:  Shashi Raj; Phillip Ruiz; Paolo Rusconi
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.